Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
Liangtao Ye(LMU Klinikum), Florian P. Reiter(LMU Klinikum), Yulong He(Model Animal Research Center), Changhua Zhang(Sun Yat-sen University), Andreas Geier(Universitätsklinikum Würzburg), Carolin Seifert(University of Würzburg), Enrico N. De Toni(LMU Klinikum), L. Frey(University of Würzburg), Julia S. Schneider(LMU Klinikum), Peter Schirmacher(Memorial Sloan Kettering Cancer Center), Najib Ben Khaled(LMU Klinikum)
Cited by 44
Related Papers
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.1k